Addition of Spironolactone in Patients With Resistant Arterial Hypertension

NCT00524615 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Hypertension

Interventions

DRUG: spironolactone

Sponsor

Jan Vaclavík

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]